DOI QR코드

DOI QR Code

Milk Transfer and Toxicokinetics of Valproic Acid in Lactating Cynomolgus Monkeys

  • 투고 : 2013.02.26
  • 심사 : 2013.03.26
  • 발행 : 2013.03.31

초록

Studies on milk transfer of drugs in non-human primates (NHPs) are among the crucial components in the assessment of peri- and postnatal toxicity because of the similarity between NHPs and humans. To evaluate the milk transfer of valproic acid (VPA) in NHPs, the toxicokinetics of VPA, an antiepileptic drug, were studied in pregnant cynomolgus monkeys. VPA was administered once daily to pregnant cynomolgus monkeys at doses of 0, 30, 90, and 270 mg/kg by oral gavage from Day 100 of gestation (GD 100) to Day 31 of lactation (LD 31). Concentrations of VPA and its metabolite, 4-ene-VPA, in the maternal plasma on GD 100, GD 140, and LD 30, and concentrations of VPA and 4-ene-VPA in the offspring plasma and milk on LDs 30 and 31, respectively, were quantified using liquid chromatography tandem mass spectrometry (LC/MS/MS). After administration of a single oral dose of VPA to pregnant monkeys on GD 100, the concentrations of VPA and 4-ene-VPA were generally quantifiable in the plasma of all treatment groups up to 24 hr after administration, which showed that VPA was absorbed and that the monkeys were systemically exposed to VPA and 4-ene-VPA. After administration of multiple doses of VPA to the monkeys, VPA was detected in the pup's plasma and in milk taken on LD 30 and LD 31, respectively, which showed that VPA was transferred via milk, and the pup was exposed to VPA. Further, the concentration of VPA in the milk increased with an increase in the dose. Extremely low concentrations of 4-ene VPA were detected in the milk and in the pup plasma. In conclusion, pregnant monkeys were exposed to VPA and 4-ene-VPA after oral administration of VPA at doses of 30, 90, and 270 mg/kg/day from GD 100 to LD 31. VPA was transferred via milk, and the VPA exposure to the pup increased with an increase in the dose of VPA. The metabolite, 4-ene VPA, was present in extremely low concentrations (< 0.5 ${\mu}g/ml$) in the milk and in the pup plasma. In this study, we established methods to confirm milk transfer in NHPs, such as mating and diagnosis of pregnancy by examining gestational sac with ultrasonography, collection of milk and pup plasma and determination of toxicokinetics, using cynomolgus monkeys.

키워드

참고문헌

  1. Ornoy, A. (2006) Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod. Toxicol., 22, 214-226. https://doi.org/10.1016/j.reprotox.2006.03.014
  2. Rosenberg, G. (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell. Mol. Life Sci., 64, 2090-2103. https://doi.org/10.1007/s00018-007-7079-x
  3. Wide, K., Winbladh, B. and Källén, B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr., 93, 174-176. https://doi.org/10.1111/j.1651-2227.2004.tb00701.x
  4. Alsdorf, R. and Wyszynski, D.F. (2005) Teratogenicity of sodium valproate. Expert Opin. Drug Saf., 4, 345-353. https://doi.org/10.1517/14740338.4.2.345
  5. Binkerd, P.E., Rowland, J.M., Nau, H. and Hendrickx, A.G. (1988) Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam. Appl. Toxicol., 11, 485-493. https://doi.org/10.1016/0272-0590(88)90112-1
  6. Hawkes, W.C., Willhite, C.C., Omaye, S.T., Cox, D.N., Choy, W.N. and Tarantal, A.F. (1994) Selenium kinetics, placental transfer, and neonatal exposure in cynomolgus macaques (Macaca fascicularis). Teratology, 50, 148-159. https://doi.org/10.1002/tera.1420500209
  7. Takahashi, M., Shibutani, M., Nakahigashi, J., Sakaguchi, N., Inoue, K., Morikawa, T., Yoshida, M. and Nishikawa, A. (2009) Limited lactational transfer of acrylamide to rat offspring on maternal oral administration during the gestation and lactation periods. Arch. Toxicol., 83, 785-793. https://doi.org/10.1007/s00204-009-0418-y
  8. Doerge, D.R., Vanlandingham, M., Twaddle, N.C. and Delclos, K.B. (2010) Lactational transfer of bisphenol A in Sprague- Dawley rats. Toxicol. Lett., 199, 372-376. https://doi.org/10.1016/j.toxlet.2010.09.022
  9. Hendrickx, A.G., Nau, H., Binkerd, P., Rowland, J.M., Rowland, J.R., Cukierski, M.J. and Cukierski, M.A. (1988) Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison. Teratology, 38, 329-345. https://doi.org/10.1002/tera.1420380405
  10. Nau, H. (1986) Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect., 70, 113-129. https://doi.org/10.1289/ehp.8670113
  11. Brown, N.A. and Fabro, S. (1983) The value of animal teratogenicity testing for predicting human risk. Chin. Obstet. Gynecol., 26, 467-477.
  12. Mast, T.J., Hendrickx, A.G. and Nau, H. (1985) Teratology and pharmacokinetics of valproic acid in the rhesus monkey. Teratology, 31, 25A.
  13. Neubert, D. and Chahoud, I. (1985) Significance of species and strain differences in pre- and perinatal toxicology. Arch. Histochem. Suppl., 31, 23-35.
  14. Schardein, J.L., Schwetz, B.A. and Kenel, M.F. (1985) Species sensitivities and prediction of teratogenic potential. Environ. Health Perspect., 61, 55-67
  15. Ornoy, A. (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod.Toxicol., 28, 1-10. https://doi.org/10.1016/j.reprotox.2009.02.014
  16. Jeong, E.J., Yu, W.J., Kim, C.Y. and Chung, M.K. (2010) Placenta transfer and toxicokinetics of valproic acid in pregnant cynomolgus monkeys. Toxicol. Res., 26, 275-283. https://doi.org/10.5487/TR.2010.26.4.275
  17. Dickinson, R.G., Lawyer, C.H., Kaufman, S.N., Lynn, R.K., Gerber, N., Novy, M.J. and Cook, M.J. (1980a) Maternofetal pharmacokinetics and fetal distribution of valproic acid in the pregnant rhesus monkey. Pediatr. Pharmacol., 1, 71-83
  18. Dickinson, R.G., Taylor, S.M., Kaufman, S.N., Rodgers, R.M., Lynn, R.K., Gerber, N. and Baughman, W.L. (1980b) Nonlinear elimination and choleretic effect of VPA in the monkey. J. Pharmacol. Exp. Ther., 213, 38-48.
  19. Ludden, T.M. (1991) Nonlinear pharmacokinetics: clinical implicantions. Clin. Pharmacokinet., 20, 429-446. https://doi.org/10.2165/00003088-199120060-00001
  20. Rettenmeier, A.W., Gordon, W.P., Prickett, K.S., Levy, R.H. and Baillie, T.A. (1986a) Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Drug Metab. Dispos., 14, 454-464.
  21. Rettenmeier, A.W., Gordon, W.P., Prickett, K.S., Levy, R.H., Lockard, J.S., Thummel, K.E. and Baillie, T.A. (1986b) Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid. Drug Metab. Dispos., 14, 443-453.
  22. Bennett, P.N. (1988) Drugs and human lactation. Elsevier, New York, pp. 341-342.
  23. von Unruh, G.E., Froescher, W., Hoffmann, F. and Niesen, M. (1984) Valproic acid in breast milk: how much is really there? Ther. Drug Monit., 6, 272-276 https://doi.org/10.1097/00007691-198409000-00003
  24. Albani, F., Riva, R., Contin, M., Baruzzi, A., Altomare, M., Merlini, G.P. and Perucca, E. (1984) Differential transplantal binding of valproic acid: influence of free fatty acids. Br. J. Clin. Pharmacol., 17, 759-762. https://doi.org/10.1111/j.1365-2125.1984.tb02414.x
  25. Tsuru, N., Maeda, T. and Tsuruoka, M. (1988) Three cases of delivery under sodium valproate-placental transfer, milk transfer and probable teratogenecity of sodium valproate. Jpn. J. Psychiatry Neurol., 42, 89-96.